<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2026-02-08 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2026-02-08/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2026-02-08"><meta property="og:description" content="ğŸ“… Daily Report - 2026-02-08 ä»Šæ—¥ç­›é€‰å‡º 63 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2026-02-08T00:00:00+00:00"><meta property="article:modified_time" content="2026-02-08T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week062026"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2026-02-08"><meta itemprop=description content="ğŸ“… Daily Report - 2026-02-08 ä»Šæ—¥ç­›é€‰å‡º 63 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2026-02-08T00:00:00+00:00"><meta itemprop=dateModified content="2026-02-08T00:00:00+00:00"><meta itemprop=wordCount content="2564"><meta itemprop=keywords content="Research,Daily,Week062026"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2026-02-08"><meta name=twitter:description content="ğŸ“… Daily Report - 2026-02-08 ä»Šæ—¥ç­›é€‰å‡º 63 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-08</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2026-02-08T00:00:00Z>2026-02-08</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2026-02-08>ğŸ“… Daily Report - 2026-02-08</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>63</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ–‡ç« æ­ç¤ºäº†æ–­å¥¶é©±åŠ¨çš„è‚ é“å¾®ç”Ÿç‰©ç»„å¦‚ä½•é€šè¿‡è¡¨è§‚é—ä¼ è°ƒæ§è‚ é“å¹²ç»†èƒï¼Œè®­ç»ƒå…ç–«è®°å¿†ï¼ˆGSE275418, GSE310995, GSE275219ï¼‰ã€‚æ­¤å¤–ï¼Œæ”¾ç–—ä¸AAVä»‹å¯¼çš„å…ç–«ç–—æ³•ååŒä½œç”¨ï¼Œæœ‰æœ›é‡å¡‘è‚¿ç˜¤å±€éƒ¨åŠå…¨èº«æŠ—è‚¿ç˜¤å…ç–«ï¼ˆGSE280079, GSE280078, GSE280080ï¼‰ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>è‚ é“å¾®ç”Ÿæ€ä¸å…ç–«</strong>ï¼šç ”ç©¶æ–­å¥¶è¿‡ç¨‹å¯¹è‚ é“å¾®ç”Ÿç‰©ç»„æˆã€è‚ é“å¹²ç»†èƒè¡¨è§‚é—ä¼ åŠå…ç–«è®°å¿†å½¢æˆçš„å½±å“ã€‚</li><li><strong>è‚¿ç˜¤å…ç–«ç–—æ³•</strong>ï¼šæ¢ç´¢æ”¾ç–—ä¸åŸºå› ç–—æ³•ï¼ˆAAVï¼‰è”åˆåœ¨è‚¿ç˜¤æ²»ç–—ä¸­çš„å…ç–«è°ƒæ§æœºåˆ¶ã€‚</li><li><strong>è¡¨è§‚é—ä¼ è°ƒæ§</strong>ï¼šæ·±å…¥è§£æTGF-Î²ã€LSD1ç­‰å…³é”®å› å­åœ¨å…ç–«è®­ç»ƒã€ç‚ç—‡åŠè‚¿ç˜¤å‘ç”Ÿå‘å±•ä¸­çš„è¡¨è§‚é—ä¼ è°ƒæ§ä½œç”¨ã€‚</li><li><strong>å•ç»†èƒå¤šç»„å­¦</strong>ï¼šåˆ©ç”¨å•ç»†èƒRNA-seqã€scATAC-seqã€scMultiomeç­‰æŠ€æœ¯è§£æå¤æ‚ç–¾ç—…ï¼ˆå¦‚ç³–å°¿ç—…ã€æ·‹å·´ç˜¤ï¼‰åŠå‘è‚²è¿‡ç¨‹ä¸­çš„ç»†èƒå¼‚è´¨æ€§ä¸è°ƒæ§æœºåˆ¶ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>å¤šç»„å­¦æ•´åˆåˆ†æ</strong>ï¼šé€šè¿‡å¤šç»´åº¦æ•°æ®ï¼ˆå¦‚RNA-seq, WGS, WGBS, scATAC-seq, scRNA-seq, Spatial Transcriptomicsï¼‰æ­ç¤ºç”Ÿç‰©å­¦è¿‡ç¨‹çš„æ·±å±‚æœºåˆ¶ã€‚</li><li><strong>æ–°å‹åŸºå› ç¼–è¾‘ä¸é€’é€æŠ€æœ¯</strong>ï¼šå¦‚AAV-basedå…ç–«ç–—æ³•ï¼Œä»¥åŠç”¨äºé¶å‘åŸºå› è°ƒæ§çš„CreERç³»ç»Ÿã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
ç ”ç©¶å‘ç°CCL3è¡¨è¾¾çš„ä¿ƒè‚¿ç˜¤ä¸­æ€§ç²’ç»†èƒçŠ¶æ€ï¼Œé¦–æ¬¡æ­ç¤ºå…¶åœ¨è·¨è‚¿ç˜¤ç±»å‹å’Œç‰©ç§ä¸­é¢„æµ‹ä¸è‰¯é¢„åçš„æ™®éæœºåˆ¶ï¼›æ–°å‹RNAæµ‹åºæŠ€æœ¯å®ç°å¯¹å¤šç§RNAä¿®é¥°çš„ç›´æ¥æ£€æµ‹ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è¯†åˆ«é¢„æµ‹ç™Œç—‡é¢„åçš„å…ç–«ç»†èƒçŠ¶æ€ï¼ˆå¦‚CCL3é«˜è¡¨è¾¾ä¸­æ€§ç²’ç»†èƒï¼‰</li><li>é˜æ˜ç»“ç›´è‚ ç™Œå…ç–«æŠ‘åˆ¶æœºåˆ¶ï¼ˆTregç»†èƒçš„ä½œç”¨ï¼‰</li><li>RNAä¿®é¥°çš„ç›´æ¥æ£€æµ‹ä¸è¡¨è§‚è½¬å½•ç»„åˆ†æ</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>åŸºäºRNAæµ‹åºçš„ä¿ƒè‚¿ç˜¤ä¸­æ€§ç²’ç»†èƒçŠ¶æ€é‰´å®š</li><li>å•ä¸€ä¿®é¥°æ„ŸçŸ¥ç¢±åŸºè¯†åˆ«æ¨¡å‹ï¼Œç›´æ¥ä»çº³ç±³å­”æ•°æ®è¯»å–RNAä¿®é¥°</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (60æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE275418 æ–­å¥¶é©±åŠ¨çš„è‚ é“å¾®ç”Ÿç‰©ç¾¤å¡‘é€ è‚ é“å¹²ç»†èƒè¡¨è§‚é—ä¼ å­¦ä»¥è®­ç»ƒå…ç–«è®°å¿†ï¼ˆRNA-seqï¼‰</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€gutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Li Yang ; Lanlan ShenSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusDuring weaning, the transition to solid food diversifies the gut microbiome, triggering a programmed immune response critical for long-lasting mucosal immunity. Previous work showed that the gut microbiome mediates epigenetic development in intestinal stem cells (ISCs) during suckling, but what happens during weaning is unclear. Here, using genome-wide methylation profiling revealed that weaning-driven microbiome changes shape the DNA methylome and transcriptome of murine ISCs in an IFN-g dependent manner. Specifically, we observe demethylation of enhancer elements essential for MHC class II genes, which result in a transcriptional memory that persists through differentiation into adulthood. IFN-g blockade, or low-dose penicillin to target Gram-positive bacteria, in early life impaired microbiome-mediated epigenetic control and mucosal immunity, and exacerbated colitis. Murine organoids primed with IFN-g showed rapid, amplified transcriptional responses upon secondary stimulations. These findings reveal that early-life events alter the gut microbiome and these changes reprogram ISC epigenetic memory to shape mucosal immunity.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275418">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE316301 è‚¿ç˜¤åŸºè´¨è›‹ç™½èšç³–çš„ç§¯ç´¯å’ŒåŠ å·¥æ”¹å˜äº†å¯¡è½¬ç§»æ€§ç»“ç›´è‚ ç™Œä¸­Tç»†èƒçš„æ•ˆåº”åŠŸèƒ½å’Œå¯¹å…ç–«ç–—æ³•çš„ååº”</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€T cellã€regex:immuno(logy|therapy|suppression)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Dustin Deming ; Sean Krau ; Joshua Brand ; Katherine Johnson ; Daniel Abbott ; Jeremy Kratz ; Anita Turk ; Philip Emmeric ; Evie Carchman ; Sam Lubner ; Noelle LoConte ; Anita Turk ; Nataliya Uboha ; Somak Chaudhuri ; Ruchi Shah ; Anna Field ; Elizabeth Field ; Cheri Pasch ; David Kim ; Sharon Weber ; Charles Heise ; Elise Lawson ; Cristina Sanger ; Kristina Matkowskyj ; Fotis Asimakopoulos ; Jens Eickhoff ; Huy Dinh ; Michael BassettiSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensVersican (VCAN) is an immunoregulatory extracellular matrix proteoglycan that when cleaved by ADAMTS proteases releases an immunostimulatory fragment, versikine. Here, we confirm that VCAN accumulates within colorectal cancers (CRCs) and inhibits T cell trafficking/effector function. VCAN is heavily proteolyzed in a subset of CRCs (VCAN proteolytic predominant (VPP)), leading to enhanced T cell infiltration. This phenotype was found to be more common in oligometastatic CRCs. A phase 1b clinical trial examined the safety/efficacy of the sequential combination of stereotactic body radiotherapy and pembrolizumab in patients undergoing resection of their microsatellite stable oligometastatic CRCs. The primary endpoint was met with a 1-year recurrence free survival (RFS) of 60%. Of those enrolled, 40% of cancers had the VPP phenotype, which was associated with improved RFS and overall survival. The VPP phenotype was associated with improved circulating T cell effector function, which was enhanced with study treatment. Clinical trial information: NCT02837263.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316301">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE280079 æ”¾å°„ç–—æ³•ä¸åŸºäº AAV çš„å…ç–«ç–—æ³•ååŒä½œç”¨ï¼Œå¯è¯±å¯¼å±€éƒ¨å’Œå…¨èº«æŠ—è‚¿ç˜¤å…ç–« [RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€regex:immuno(logy|therapy|suppression)ã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Juan Dubrot ; JesÃºs Prieto ; Elizabeth Guruceaga ; Sonia MarcoSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusRadiotherapy (RT) primes the immune system against cancer antigens but fails to trigger effective antitumor responses due to concomitant induction of immunosuppressive factors. To expand the benefits of RT, we combine local radiation with immuno-gene therapy by harnessing the ability of ionizing radiation to enhance AAV-mediated tumor transduction. To successfully deliver AAV-based local immunotherapy and restrict transgene expression within tumors, we designed a recombinant AAV that expresses IL-12 through an interferon (IFN)-inducible promoter (AAV-iIL12). Local administration of AAV-iIL12 upon RT results in marked and durable elevation of intratumor IL-12 with minor and transient systemic release. This strategy generates a highly immunostimulatory tumor microenvironment (TME) leading to strong antitumor responses in an IFNg-dependent manner. Moreover, local treatment with RT and AAV-iIL12 elicits systemic antitumor immunity with marked CD8+ T cell infiltration and regression of distant tumors. Our work shows that radiation coupled with AAV-based immuno-gene delivery is a novel, efficient and safe approach that can be exploited as cancer therapy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280079">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE280078 æ”¾å°„ç–—æ³•ä¸åŸºäº AAV çš„å…ç–«ç–—æ³•ååŒä½œç”¨ï¼Œå¯è¯±å¯¼å±€éƒ¨å’Œå…¨èº«æŠ—è‚¿ç˜¤å…ç–« [scRNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€regex:immuno(logy|therapy|suppression)ã€scRNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Juan Dubrot ; JesÃºs Prieto ; Elizabeth Guruceaga ; Seth Anderson ; Sonia MarcoSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusRadiotherapy (RT) primes the immune system against cancer antigens but fails to trigger effective antitumor responses due to concomitant induction of immunosuppressive factors. To expand the benefits of RT, we combine local radiation with immuno-gene therapy by harnessing the ability of ionizing radiation to enhance AAV-mediated tumor transduction. To successfully deliver AAV-based local immunotherapy and restrict transgene expression within tumors, we designed a recombinant AAV that expresses IL-12 through an interferon (IFN)-inducible promoter (AAV-iIL12). Local administration of AAV-iIL12 upon RT results in marked and durable elevation of intratumor IL-12 with minor and transient systemic release. This strategy generates a highly immunostimulatory tumor microenvironment (TME) leading to strong antitumor responses in an IFNg-dependent manner. Moreover, local treatment with RT and AAV-iIL12 elicits systemic antitumor immunity with marked CD8+ T cell infiltration and regression of distant tumors. Our work shows that radiation coupled with AAV-based immuno-gene delivery is a novel, efficient and safe approach that can be exploited as cancer therapy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280078">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE279313 TGF-Î² æ§åˆ¶ IFN æŠ—ç—…æ¯’è®­ç»ƒå…ç–«çš„è¡¨è§‚é—ä¼ é‡ç¼–ç¨‹å¹¶æŸå®³ SIV æ„ŸæŸ“æ’æ²³çŒ´çš„ç—…æ¯’æ§åˆ¶ [bulk RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€RNA-seqã€epigenetic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Felipe ten-Caten ; Khader Ghneim ; Mirko Paiardini ; Susan P Ribeiro ; Rafick P SekalySeries Type : Expression profiling by high throughput sequencingOrganism : Macaca mulattaCurrent immunotherapeutic approaches to eliminate latently HIV-infected cells have focused on targeting the adaptive arm of the immune system using vaccines and passive transfer of broadly neutralizing antibodies (bNAbs). Epigenetic reprogramming of innate myeloid cells triggered by adjuvants was recently shown to promote a state of interferon (IFN)-induced antiviral immunity and resistance to heterologous viral infections. Herein, flow cytometry, bulk and single-cell RNA-Seq/ATAC-Seq were performed on samples from a cohort of SIV-infected, virologically suppressed rhesus macaques (RMs) treated with anti-IL-10 and anti-PD-1 monoclonal antibodies (combo treatment) prior to analytical treatment interruption (ATI). These experiments revealed that combo treatment led to selective changes in chromatin accessibility, expression of IRF7/3 and STAT1, and expression of IFN-stimulated antiviral genes in myeloid cells and CD4+ T cells. These RMs showed a stringent and prolonged control of SIV viral rebound following ATI and a decay in levels of cell-associated viral DNA (CA-vDNA) in lymph nodes. These RMs showed reduced chromatin accessibility for the SMAD2/SMAD3, AP-1, and NFKB1 loci and lower expression of TGF-b and SMADs target genes. This signature is consistent with that observed in HIV elite controllers, who maintain undetectable levels of virus in the absence of ART and whose HIV reservoir size is small. These results highlight the critical role of the interplay between TGF-b and IFN in epigenetically regulated innate antiviral immune responses that can impact the viral reservoir.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279313">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE314342 äººç±»åŸä»£ CD4+ T ç»†èƒçš„åŸºå› ç»„è§„æ¨¡æ‰°åŠ¨æµ‹åºæ­ç¤ºäº†è°ƒæ§ T ç»†èƒç¨‹åºå’Œäººç±»å…ç–«ç‰¹å¾çš„åŸºå› ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€T cellã€genome</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ronghui Zhu ; Emma Dann ; Jun Yan ; Justine Reyes Retana ; Ryunosuke Goto ; Reese C Guitche ; Lillian K Petersen ; Mineto Ota ; Brian R Shy ; Jonathan K Pritchard ; Alexander MarsonSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensCD4+ T cells orchestrate immune responses against infection and cancer, yet a comprehensive map of their gene regulatory networks has been lacking. Perturb-seq enables systematic mapping of such networks, but large-scale application in primary human T cells has been challenging. Here, we developed a scalable, probe-based Perturb-seq platform and performed genome-scale perturbations of all expressed genes across 22 million primary CD4+ T cells from four donors under three stimulation conditions. We demonstrate the utility of this dataset in three ways. First, we identify previously unrecognized regulators of the two important immune cytokines, IL-10 and IL-21. Second, we show that ex vivo perturbation signatures can model T cell states observed in population-scale atlases, revealing regulators of helper T cell polarization and T cell aging. Third, we leverage regulatory relationships to mechanistically explain geneâ€“trait associations in immune-related diseases, nominating genes for uncharacterized immune functions. Thus genome-scale perturb-seq in primary human T cells provides a foundational resource for decoding immune variation in humans and reprogramming T cell states for next-generation precision therapies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314342">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE310995 æ–­å¥¶é©±åŠ¨çš„è‚ é“å¾®ç”Ÿç‰©ç¾¤å¡‘é€ è‚ é“å¹²ç»†èƒè¡¨è§‚é—ä¼ å­¦ä»¥è®­ç»ƒå…ç–«è®°å¿†ï¼ˆå…¨åŸºå› ç»„æµ‹åºï¼‰</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Li Yang ; Lanlan ShenSeries Type : OtherOrganism : Mus musculusDuring weaning, the shift from milk to solid food is accompanied by a rapid expansion and diversification of the gut microbiome. This triggers the weaning reaction, a programmed immune response important for long-lasting mucosal immunity that is poorly understood. Here, we characterize the impact of the gut microbiome on the DNA methylome and transcriptome of intestinal stem cells (ISCs) from weaning to young adulthood in mice. We identify a weaning- IFN-g-TET3 axis that reprograms epithelial MHC-II signaling via enhancer demethylation in ISCs, establishing a lasting transcriptional memory into adulthood. Disruption of this axis by IFN-g blockade or low-dose penicillin attenuates the microbiota-mediated epigenetic control of epithelial MHC-II signaling, leading to impaired mucosal immunity. By engaging immune crosstalk and metabolite production, the weaning microbiome drives epigenetic reprogramming, thereby establishing a microbiome-induced regulatory pathway that couples developmental cues to lifelong epithelial immune resilience.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310995">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>GSE275219 æ–­å¥¶é©±åŠ¨çš„è‚ é“å¾®ç”Ÿç‰©ç¾¤å¡‘é€ è‚ é“å¹²ç»†èƒè¡¨è§‚é—ä¼ å­¦ä»¥è®­ç»ƒå…ç–«è®°å¿† (WGBS)</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Li Yang ; Lanlan ShenSeries Type : Methylation profiling by high throughput sequencingOrganism : Mus musculusDuring weaning, the transition from milk to solid food rapidly expands and diversifies the gut microbiome, triggering the weaning reaction, a programmed immune response critical for long-lasting mucosal immunity. We characterized how these microbiome changes from weaning through young adulthood in mice shape the DNA methylome and transcriptome of intestinal stem cells (ISCs). We identified a weaning-induced IFN-gâ€“TET3 axis as a key driver of MHC class II enhancer-linked epigenetic reprogramming, creating a transcriptional memory that persists through differentiation into adulthood. Early-life disruption of this axis, via IFN-g blockade or low-dose penicillin, impaired microbiota-mediated epigenetic control and mucosal immunity. Weaning-associated microbiome shifts enriched metabolites such as Î±-ketoglutarate, Fe2+, and methionine g-lyase, promoting TET-dependent DNA demethylation. These findings reveal how early-life events imprint lifelong epigenetic regulation of mucosal immunity, highlighting epithelial cells as innate immune sentinels that acquire trained transcriptional memory in response to microbial cues.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275219">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>GSE318371 æ–°è¯Šæ–­çš„NK/Tç»†èƒæ·‹å·´ç˜¤æ‚£è€…å¤–å‘¨è¡€å•æ ¸ç»†èƒå•ç»†èƒå›¾è°±</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šlymphomaã€T cellã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xiaozhen Liang ; Rong Tao ; Ran Jia ; Chuanxu LiuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensNatural killer/T cell lymphoma (NKTCL) is a rare and aggressive form of non-Hodgkin&rsquo;s lymphoma associated with Epstein-Barr Virus (EBV) infection.The recent advancement of multi-omics technologies has significantly enhanced our understanding of NKTCL disease biology, including genetics, transcription landscape, variations of EBV strain, and microenvironments. Emerging evidence suggests that immunoprofiling of peripheral blood mononuclear cells (PBMCs) is associated with the treatment response of cancer patients and can be used to guide clinical trials and therapy. In this study, we utilized single-cell RNA sequencing (scRNA-seq) to comprehensively characterize the phenotypic landscape of PBMCs in newly diagnosed patients with NKTCL. This research offers a valuable peripheral blood-based signature for newly diagnosed NKTCL, which could be a crucial resource for further investigations into the pathogenesis of NKTCL and the optimization of therapeutic regimens.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318371">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>GSE317297 åµå·¢ç‚ç—‡è¡°è€çš„å¤šç»†èƒèµ·æº [ç©ºé—´è½¬å½•ç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Anna Galligos ; Joseph Varberg ; Wei-Ting Yueh ; Aubrey Converse ; Seth Malloy ; Fatimah Aljubran ; Francesca E Duncan ; Jennifer L GertonSeries Type : OtherOrganism : Mus musculusAge-dependent reproductive decline has become a significant global health concern as the average maternal age at first birth increases. Fertility loss associated with reproductive aging is driven in part by alterations to ovarian composition and function, dysregulation of folliculogenesis and increased inflammatory signaling. Our understanding of the molecular changes underlying ovarian aging has been expanded by single cell and spatial transcriptomic studies, which identified infiltration of immune cells as a feature of ovarian aging. However, the function of these age-associated immune cells and their potential contributions to the inflammaging phenotype remains unclear. In this study we integrate single cell and spatial transcriptomics to define changes in the composition and intercellular signaling in the aging mouse ovary. We identify specific macrophage and T cell subpopulations that increase with age and are key sources of pro-inflammatory signaling in old ovaries. Further, we predict bidirectional signaling between these pro-inflammatory cells and granulosa cell populations that may impair follicular growth and development while promoting immune cell recruitment. These findings provide new insights into the mechanisms that drive ovarian inflammaging.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317297">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 50 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨3æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4><p><strong>1.</strong> <strong>ä¸€ç§å…ç–«å˜é‡å¯ä»¥é¢„æµ‹ä¸åŒè‚¿ç˜¤ç±»å‹å’Œç‰©ç§çš„ä¸è‰¯é¢„åã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immune</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šUsing RNA sequencing, researchers identify a conserved pro-tumor neutrophil state marked by CCL3 expression, revealing how specific immune cell programs support cancer growth across tumor types&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/one-immune-variable-predicts-poor-outcomes-across-tumor-types-and-species/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>ä¸ºä»€ä¹ˆç»“ç›´è‚ ç™Œä¼šæ‰“ç ´å…ç–«ç³»ç»Ÿçš„è§„åˆ™</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immune</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šColorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are packed with immune-suppressing regulatory T cells. New research finally explains why. Scientists discovered that these T cells arenâ€™t all the same: one subtype actually helps keep tumors in check, while another shields cancer from immune attack. The balance between these â€œgoodâ€ and â€œbadâ€ cells can determine whether a tumor grows or shrinks.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/02/260206012229.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>åˆ©ç”¨çº³ç±³å­”æµ‹åºç›´æ¥è¯»å–RNAä¿®é¥°</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencing</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šNew RNA sequencing tools enable direct detection of multiple RNA modifications from nanopore data, simplifying epitranscriptome analysis with a single modification-aware basecalling model&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/reading-rna-modifications-directly-with-nanopore-sequencing/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>immunity</td><td>13</td></tr><tr><td>tumor</td><td>12</td></tr><tr><td>single-cell</td><td>7</td></tr><tr><td>RNA-seq</td><td>7</td></tr><tr><td>immune</td><td>6</td></tr><tr><td>cancer</td><td>6</td></tr><tr><td>scRNA</td><td>5</td></tr><tr><td>regex:immuno(logy</td><td>therapy</td></tr><tr><td>regex:intestin(e</td><td>al)</td></tr><tr><td>sequencing</td><td>3</td></tr><tr><td>T cell</td><td>3</td></tr><tr><td>gut</td><td>3</td></tr><tr><td>regex:gut(-?microbiome)?</td><td>3</td></tr><tr><td>methylation</td><td>2</td></tr><tr><td>ATAC-seq</td><td>2</td></tr><tr><td>epigenetic</td><td>2</td></tr><tr><td>transcriptome</td><td>2</td></tr><tr><td>RNAseq</td><td>2</td></tr><tr><td>inflammation</td><td>2</td></tr><tr><td>spatial</td><td>2</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (50æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318384">GSE318384 æ•´åˆå¤šç»„å­¦åˆ†ææ­ç¤º METTL3 è¿‡è¡¨è¾¾åœ¨ A549 è‚ºç™Œç»†èƒä¸­å¼•èµ·çš„æŠ‘ç™Œè¡¨å‹åŠç›¸å…³è½¬å½•ç»„é‡å¡‘</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298505">GSE298505 è›‹ç™½æ¿€é…¶ CK2Î±â€™ ä½œä¸º Tau è›‹ç™½ç—…ä¸­å…ç–«ä¿¡å·ä¼ å¯¼å’Œçªè§¦åŠŸèƒ½éšœç¢çš„åŒé‡è°ƒèŠ‚å› å­</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294115">GSE294115 å•ç»†èƒå¤šæ¨¡æ€åˆ†ææ­ç¤ºç³–å°¿ç—…å°é¼ å°½ç®¡è¡€ç³–æ§åˆ¶è‰¯å¥½ï¼Œä¸»åŠ¨è„‰å¹³æ»‘è‚Œç»†èƒä»æŒç»­å‘ç”Ÿå˜åŒ– [scATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294114">GSE294114 å•ç»†èƒå¤šæ¨¡æ€åˆ†ææ­ç¤ºç³–å°¿ç—…å°é¼ å°½ç®¡è¡€ç³–æ§åˆ¶è‰¯å¥½ï¼Œä¸»åŠ¨è„‰å¹³æ»‘è‚Œç»†èƒä»æŒç»­å‘ç”Ÿå˜åŒ– [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282071">GSE282071 æ‹Ÿå—èŠ¥ ROS1 åœ¨è°ƒèŠ‚æŸ“è‰²è´¨å¯åŠæ€§å’Œ DNA ç”²åŸºåŒ–ä¸­çš„å¤šç§ä½œç”¨ [ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280080">GSE280080 æ”¾å°„ç–—æ³•ä¸åŸºäºAAVçš„å…ç–«ç–—æ³•ååŒä½œç”¨ï¼Œå¯è¯±å¯¼å±€éƒ¨å’Œå…¨èº«æŠ—è‚¿ç˜¤å…ç–«ååº”ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279314">GSE279314 TGF-Î² æ§åˆ¶ IFN æŠ—ç—…æ¯’è®­ç»ƒå…ç–«çš„è¡¨è§‚é—ä¼ é‡ç¼–ç¨‹ï¼Œå¹¶æŸå®³ SIV æ„ŸæŸ“æ’æ²³çŒ´çš„ç—…æ¯’æ§åˆ¶ [scMultiome]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318611">GSE318611 æœè‡é»‘è…¹æœè‡å—…è§‰æŠ•å°„ç¥ç»å…ƒåœ¨è›¹å½¢æˆå 12 å°æ—¶ (h APF) çš„å•ç»†èƒè½¬å½•ç»„è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302760">GSE302760 æŠ‘åˆ¶LSD1å¯è§£é”ç±»è§†é»„é†‡AP-1ç¨‹åºï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302485">GSE302485 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [RNAseq_LSD1iRARi]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302483">GSE302483 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [CutRun_LSD1i48h]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302480">GSE302480 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [CreERTRNAseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302477">GSE302477 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [CreERTCutRun]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302474">GSE302474 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [Xenium CreERT]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302473">GSE302473 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [Xenium è‚¿ç˜¤]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302470">GSE302470 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [Xenium èƒšèƒ]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299107">GSE299107 ç‚ç—‡æ€§ epiCaspase-1 é€šè¿‡è¿œç¨‹åå‘éª¨é«“é€ è¡€æ¥æŠ‘åˆ¶å…ç–«åŸæ€§ç»†èƒæ­»äº¡ï¼Œä»è€Œé©±åŠ¨ä»¥ä¸­æ€§ç²’ç»†èƒä¸ºä¸»çš„å…¨èº«æ€§ç‚ç—‡ [T24 RNAseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317789">GSE317789 å•ç»†èƒå’Œç©ºé—´åˆ†ææ­ç¤ºäº†çš®è‚¤å’Œé»è†œæ‰å¹³è‹”è—“ä¸­ cDC2A-CXCL13+ CD8+ T ä¸Šçš®ç»†èƒé€šè¿‡ TNFRSF9 è¿›è¡Œä¸²æ‰°å’Œç»†èƒæ¯’æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318649">GSE318649 è½½ä½“å’Œè°·æ°¨é…¸ç¡¼é…¸å¤„ç†å°é¼ è„¾è„å…ç–«ç»†èƒçš„å•ç»†èƒRNAæµ‹åºæ•°æ®[é‡å¤å®éªŒ]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289185">GSE289185 æ–°è¾…åŠ©æ”¾ç–—å’Œå…ç–«ç–—æ³•æ²»ç–—é£Ÿç®¡é³çŠ¶ç»†èƒç™Œçš„å®‰å…¨æ€§å’Œæœ‰æ•ˆæ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294237">GSE294237 å•ç»†èƒå¤šæ¨¡æ€åˆ†ææ­ç¤ºç³–å°¿ç—…å°é¼ å°½ç®¡è¡€ç³–æ§åˆ¶è‰¯å¥½ï¼Œä¸»åŠ¨è„‰å¹³æ»‘è‚Œç»†èƒä»æŒç»­å‘ç”Ÿæ”¹å˜</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291420">GSE291420 è§£è¯»å°é¼ å„å™¨å®˜è¡°è€çš„è½¬å½•ç»„ç‰¹å¾</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289338">GSE289338 RNA-Seq åˆ†æäººè¶³ç»†èƒä¸­ ATOH8 æ•²ä½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282075">GSE282075 ROS1ï¼šæ‹Ÿå—èŠ¥ä¸­å¯åŠæŸ“è‰²è´¨çš„å…³é”®æ ‡è®°å’Œè°ƒèŠ‚å› å­ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282073">GSE282073 æ‹Ÿå—èŠ¥ ROS1 åœ¨è°ƒèŠ‚æŸ“è‰²è´¨å¯åŠæ€§å’Œ DNA ç”²åŸºåŒ–ä¸­çš„å¤šç§ä½œç”¨ [äºšç¡«é…¸æ°¢ç›æµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282072">GSE282072 ROS1: Key Marker and Regulator of Accessible Chromatin in Arabidopsis [ATAC-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281781">GSE281781 MYC ä¸æ–°ç”Ÿ RNA çš„ç»“åˆé€šè¿‡ R ç¯è¡ç”Ÿçš„ RNA-DNA æ‚äº¤ä½“æŠ‘åˆ¶å…ˆå¤©å…ç–«ä¿¡å·ä¼ å¯¼</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE259427">GSE259427 miR-203 æ§åˆ¶æ¤å…¥å‰èƒšèƒå‘ç”Ÿè¿‡ç¨‹ä¸­çš„å‘è‚²æ—¶åºå’Œæ—©æœŸå‘½è¿é™åˆ¶ï¼ˆscRNA-Seqï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE259426">GSE259426 miR-203 æ§åˆ¶æ¤å…¥å‰èƒšèƒå‘ç”Ÿè¿‡ç¨‹ä¸­çš„å‘è‚²æ—¶åºå’Œæ—©æœŸå‘½è¿é™åˆ¶ï¼ˆRNA-Seqï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317412">GSE317412 è†³é£Ÿè°·æ°¨é…°èƒºè¡¥å……å‰‚é€šè¿‡é™åˆ¶ H3K27me3 æ¥ç¼“è§£ä¸å¹´é¾„ç›¸å…³çš„å¿ƒè„è¡°é€€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313923">GSE313923 é¶å‘æ·‹å·´ç®¡å¯é€šè¿‡å¢å¼ºå°é¼ æˆªè‚¢æ¨¡å‹ä¸­çš„ç ´éª¨ç»†èƒæ´»æ€§æ¥ä¿ƒè¿›éª¨å†ç”Ÿ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307297">GSE307297 ç±»é£æ¹¿æ€§å…³èŠ‚ç‚ç›¸å…³é—´è´¨æ€§è‚ºç–¾ç—…çš„å•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305629">GSE305629 è‚Œå±‚æµ¸æ¶¦æ€§è†€èƒ±ç™Œ (MIBC) ä¸­çš„ä¸­æ€§ç²’ç»†èƒå’Œ CD8+ T ç»†èƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304377">GSE304377 è¥å…»åŸºå› ç»„å­¦æ­ç¤ºç»´ç”Ÿç´  B3 ç–—æ³•å¯æ²»æ„ˆ NAXD ç–¾ç—…</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303721">GSE303721 è‚¾ç™Œä¸­SOCS3â€“JAK1â€“STAT3è½´ä»‹å¯¼çš„HIF-2Î±å¢å¼ºå­è°ƒæ§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298565">GSE298565 ä½¿ç”¨ PATTY æ ¡æ­£æ‰¹é‡å’Œå•ç»†èƒ CUT&amp;Tag æ•°æ®ä¸­çš„å¼€æ”¾æŸ“è‰²è´¨åå€š [CUT&amp;Tag]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298319">GSE298319 ç‚ç—‡æ€§è¡¨è§‚Caspase-1é€šè¿‡è¿œç¨‹è°ƒæ§éª¨é«“é€ è¡€ï¼Œé©±åŠ¨ä»¥ä¸­æ€§ç²’ç»†èƒä¸ºä¸»çš„å…¨èº«æ€§ç‚ç—‡ï¼Œä»è€ŒæŠ‘åˆ¶å…ç–«åŸæ€§ç»†èƒæ­»äº¡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314609">GSE314609 é…®ä½“Î²-ç¾ŸåŸºä¸é…¸é€šè¿‡éä»£è°¢ä¾èµ–æ€§æœºåˆ¶æ¢å¤Tauè›‹ç™½ç¨³æ€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311934">GSE311934 åº”æ¿€è¯±å¯¼çš„ ADGRL4 é€šè¿‡ GÎ±s-YAP1 ä¿¡å·é€šè·¯å’Œè¡€ç®¡ç”Ÿæˆè°ƒæ§è‚¿ç˜¤ä¼‘çœ å’Œå¤å‘</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299422">GSE299422 å¯¹å…±åŸ¹å…»çš„ç™Œç»†èƒ-å®¿ä¸»ç»†èƒè¿›è¡Œè½¬å½•ç»„åˆ†æï¼Œå‘ç°ç¼ºæ°§æ˜¯éª¨éª¼è‚Œç»†èƒæŠ‘åˆ¶ç™Œç»†èƒå¢æ®–ä½œç”¨çš„é©±åŠ¨å› ç´ ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296363">GSE296363ï¼šå¯¹å•ä¸ªåµæ¯ç»†èƒè¿›è¡Œå°RNAå’Œé•¿RNAçš„æ•´åˆæµ‹åºæ­ç¤ºäº†äººç±»åµå­å‘ç”Ÿè¿‡ç¨‹ä¸­piRNAä»‹å¯¼çš„è½¬åº§å­æŠ‘åˆ¶ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289182">GSE289182 è¡¨è§‚è½¬å½•ç»„åˆ†ææ­ç¤ºäº†ä¸¤ç§è¥¿ç“œæ„ŸæŸ“çš„RNAç—…æ¯’ä¸­ä¸å­˜åœ¨m6Aä¿®é¥°</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318449">GSE318449 Wnt7a-Hoxa13é€šè·¯åœ¨å­å®«å½¢æ€å‘ç”Ÿè¿‡ç¨‹ä¸­ä¿ƒè¿›ä½“ä¸­çº¿è‹—å‹’æ°ç®¡èåˆ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318448">GSE318448 è¯ç†å­¦æ–¹æ³•æé«˜ä¹³é…¸æ°´å¹³å¯é€šè¿‡ç»„è›‹ç™½ä¹³åŒ–è¯±å¯¼çš„IL-10äº§ç”Ÿç¼“è§£è„“æ¯’ç—‡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289127">GSE289127 é‡‘å¤´é²·è‚ é“çš„å®æ—¶å®šé‡PCRåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286304">GSE286304 ä¹™é…¸ç›å¯ä¿ƒè¿›çº¢é…µæ¯èŒï¼ˆRhodotorula toruloidesï¼‰çš„æœ¨ç³–ä»£è°¢</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268657">GSE268657 Isl1CKOå°é¼ æ¨¡å‹å†…åˆ†æ³Œèƒ°è…ºè°±ç³»çš„å•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252636">GSE252636 å°é¼ è„¾è„æ¥æºçš„å¹¼ç¨šTç»†èƒã€ä¸­å¤®è®°å¿†Tç»†èƒå’Œæ•ˆåº”è®°å¿†Tç»†èƒçš„RNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE224872">GSE224872 ATAC-seq æ•°æ®æ¥è‡ªåœ¨ OVA257-264 åˆºæ¿€ä¸‹ä¸è½½ä½“æˆ– TAMos å…±åŸ¹å…»çš„ OT-I ç»†èƒã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE224871">GSE224871 RNA-seq åˆ†æäº†åœ¨ OVA257-264 åˆºæ¿€ä¸‹ï¼Œä¸è½½ä½“ã€TANs æˆ– TAMos å…±åŸ¹å…»çš„ OT-I ç»†èƒã€‚</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-07 21:46</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week062026/ rel=tag>Week062026</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2026-02-07/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-07</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2026-02-09/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-09</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-22/>ç§‘ç ”æ—¥æŠ¥ 2026-02-22</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-21/>ç§‘ç ”æ—¥æŠ¥ 2026-02-21</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-20/>ç§‘ç ”æ—¥æŠ¥ 2026-02-20</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-19/>ç§‘ç ”æ—¥æŠ¥ 2026-02-19</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-18/>ç§‘ç ”æ—¥æŠ¥ 2026-02-18</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (115)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (115)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week072026/ title=Week072026>Week072026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week082026/ title=Week082026>Week082026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>